Patents by Inventor Samarth Kumar
Samarth Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190117560Abstract: A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.Type: ApplicationFiled: December 19, 2018Publication date: April 25, 2019Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
-
Publication number: 20190105262Abstract: The present invention relates to an intravenous infusion dosage form comprising: an aqueous solution of pemetrexed or its pharmaceutically acceptable salt at a concentration ranging from 1.0 mg/ml to 20.0 mg/ml present in a multilayered flexible plastic infusion container, wherein the multilayered flexible plastic infusion container has an oxygen scavenger layer sandwiched between an outermost and an innermost layer of the container, the container being free of a polyamide and wherein the multilayered flexible plastic infusion container filled with the aqueous solution of pemetrexed is autoclavable.Type: ApplicationFiled: October 10, 2018Publication date: April 11, 2019Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Samarth KUMAR, Ramaji Karshanbhai VARU, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
-
Publication number: 20190070110Abstract: The present invention provides a parenteral dosage form consisting essentially of a solution filled in a container, the solution comprising amiodarone or its pharmaceutically acceptable salt and a sulfo-alkyl ether beta-cyclodextrin in an aqueous vehicle, wherein the solution has a pH in the range of about 2.4 to 3.9 and further wherein the dosage form is sterilized by subjecting the filled container to autoclaving.Type: ApplicationFiled: March 3, 2017Publication date: March 7, 2019Inventors: Samarth KUMAR, Soni Maheshkumar PARASMAL, Milan Mohanbhai VASOYA, Prashant KANE, Subhas Balaram BHOWMICK, Rajamannar THENNATI
-
Patent number: 10206872Abstract: A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.Type: GrantFiled: June 17, 2016Date of Patent: February 19, 2019Assignee: SUN PHARMACUETICAL INDUSTRIES LTD.Inventors: Samarth Kumar, Prashant Kane, Subhas Balaram Bhowmick, Milan Natvarbhai Thakkar, Kandarp Maheshkumar Dave
-
Publication number: 20190046398Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.Type: ApplicationFiled: October 12, 2018Publication date: February 14, 2019Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Kirti GANORKAR, Nishit PATEL, Ashish Anilrao DUBEWAR, Umeshkumar Mukeshbhai PATEL
-
Publication number: 20190008847Abstract: The present invention relates to a dosage form comprising an aqueous solution of a vinca alkaloid drug or its pharmaceutically acceptable salt in a flexible infusion container, and a light protective secondary packaging containing the flexible infusion container, wherein the dosage form is ready-to-infuse and wherein the aqueous solution is stable at room temperature.Type: ApplicationFiled: August 1, 2016Publication date: January 10, 2019Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Subhas Balaram BHOWMICK, Prashant KANE, Samarth KUMAR, Ramaji Karshanbhai VARU, Nisarg Bipinchandra MISTRY, Swapnil Ramesh PATIL
-
Patent number: 10098813Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.Type: GrantFiled: September 2, 2015Date of Patent: October 16, 2018Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth Kumar, Prashant Kane, Balaram Subhas Bhowmick, Kirti Ganorkar, Nishit Patel, Anilrao Ashish Dubewar, Mukeshbhai Umeshkumar Patel
-
Publication number: 20180140563Abstract: The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.Type: ApplicationFiled: January 19, 2018Publication date: May 24, 2018Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Rakesh THUMMAR, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Samarth KUMAR, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
-
Publication number: 20180064703Abstract: The present invention relates to an infusion dosage form comprising (i) an aqueous solution of morphine or its pharmaceutically acceptable salt as a sole active ingredient in a concentration ranging from about 0.1 mg/ml to about 10.0 mg/ml, filled in containers in volumes ranging from about 50 ml to about 250 ml, and having dissolved oxygen content of less than 2 ppm, (ii) the container being surrounded by an outer covering, and (iii) an inert gas or vacuum is present in the space between the container and outer covering, wherein the infusion dosage form is sterilized by autoclaving and is stable upon autoclaving, and further wherein the space between the container and outer covering does not have an oxygen scavenger pouch before or during autoclaving.Type: ApplicationFiled: September 1, 2017Publication date: March 8, 2018Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
-
Publication number: 20180036310Abstract: The present invention relates to an intravenous infusion dosage form of pemetrexed or its pharmaceutically acceptable salt, having long term stability.Type: ApplicationFiled: February 12, 2016Publication date: February 8, 2018Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Kirti GANORKAR, Nisarg Bipinchandra MISTRY, Ramaji Karshanbhai VARU
-
Patent number: 9757352Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: GrantFiled: April 18, 2017Date of Patent: September 12, 2017Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai Rana, Shantaram Pawar, Prashant Kane, Subhas Balaram Bhowmick, Maheshkumar Parasmal Soni, Milan Mohanbhai Vasoya, Samarth Kumar
-
Publication number: 20170216243Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: ApplicationFiled: April 18, 2017Publication date: August 3, 2017Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai RANA, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Maheshkumar Parasmal SONI, Milan Mohanbhai VASOYA, Samarth KUMAR
-
Patent number: 9642828Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: GrantFiled: September 21, 2015Date of Patent: May 9, 2017Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai Rana, Shantaram Pawar, Prashant Kane, Subhas Balaram Bhowmick, Maheshkumar Parasmal Soni, Milan Mohanbhai Vasoya, Samarth Kumar
-
Publication number: 20160367476Abstract: A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.Type: ApplicationFiled: June 17, 2016Publication date: December 22, 2016Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
-
Publication number: 20160081972Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.Type: ApplicationFiled: September 21, 2015Publication date: March 24, 2016Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Amar Kishorbhai RANA, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Maheshkumar Parasmal SONI, Milan Mohanbhai VASOYA, Samarth KUMAR
-
Publication number: 20160058663Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.Type: ApplicationFiled: September 2, 2015Publication date: March 3, 2016Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth KUMAR, Prashant KANE, Balaram Subhas BHOWMICK, Kirti GANORKAR, Nishit PATEL, Anilrao Ashish DUBEWAR, Mukeshbhai Umeshkumar Patel
-
Patent number: 9241948Abstract: A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused.Type: GrantFiled: April 26, 2013Date of Patent: January 26, 2016Assignee: Sun Pharmaceutical Industries Ltd.Inventors: Samarth Kumar, Prashant Kane, Alok B. Namdeo, Subhas B Bhowmick, Kirti Ganorkar
-
Publication number: 20130288994Abstract: A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused.Type: ApplicationFiled: April 26, 2013Publication date: October 31, 2013Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Samarth Kumar, Prashant Kane, Alok B. Namdeo, Subhas B. Bhowmick, Kirti Ganorkar